Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 5, September-October, p. 911–921

doi: 10.17219/acem/26324

Publication type: review

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Medical and Ethical Considerations Related to Viable Fetuses with Trisomy 13 in the 36th Week of Pregnancy – a Review of the Literature

Małgorzata Pawelec1,A,B,C,D, Małgorzata Dżugalik2,A,B, Jolanta Pietras2,E,F, Łukasz Bełza1,B, Łukasz Latkowski1,B

1 First Clinic of Gynecology and Obstetrics, Wroclaw Medical University, Poland

2 Faculty of Nursing, LZDZ Medical College in Legnica, Poland

Abstract

Patau syndrome was first described in 1960 as a group of birth defects caused by trisomy of chromosome 13 (T13). Providing accurate information and relevant reproductive genetic counseling that would allow parents to make informed decisions is not easily accomplished because of the limited information available prenatally. Only 1/3 of all cases of T13 are diagnosed prenatally, which means it cannot be expected that most cases will be detected early in pregnancy, that the parents will decide to terminate the pregnancy, and that difficulties will be avoided. There is no good prenatal screening for T13, and there are many kinds and degrees of anomalies. About 60% of cases are first detected in the second trimester, and life expectancy is difficult to predict. When patients choose not to terminate pregnancy, or when the pregnancy has progressed to a viable gestational age, pregnancy termination is no longer an option. Also, nowadays 12% of couples choose to continue pregnancy following chromosomal confirmation of a suspected T13. The aim of this work is to eludicate for health care providers what problems they are likely to face in the care of children with T13 and in contact with their parents. It is crucial for the management of each case to discuss neonatal procedures of resuscitation, alternatives to aggressive resuscitation, the possibilities for correcting some of the defects, and to be prepared to guide the parents through the trauma of having a child with a lethal defect.

Key words

Patau syndrome, trisomy 13, holoprosencephaly, aneuploidy

References (55)

  1. Patau K, Smith DW, Therman E, Inhorn SL, Wagner HP: Multiple congenital anomaly caused by an extra autosome. Lancet 1960, 1, 790–796.
  2. Costa AD, Schultz R, Rosemberg S: Alobar holoprosencephaly and trisomy 13 (Patau syndrome). Autopsy Case Rep 2013, 3, 5–10.
  3. Jones LA, Taysi K, Strauss AW, Hartmann AF: Partial trisomy 13 as a result of de novo (6p;13q) translocation. Hum Genet 1979, 48, 245–249.
  4. Vekemans M, Morichon-Delvallez N: Duplication of the long arm of chromosome 13 secondary to a recombination in a maternal intrachromosomal insertion (shift). Prenat Diagn 1990, 10, 787–794.
  5. Chen CP: Placental abnormalities and preeclampsia in trisomy 13 pregnancies. Taiwan J Obstet Gynecol 2009, 48, 3–8.
  6. Kim HJ, Hsu LYF, Goldsmith LC, Strauss L, Hirschhorn K: Familial translocation with partial trisomy of 13 and 22: evidence that specific regions of chromosomes 13 and 22 are responsible for phenotype of each trisomy. J Med Genetics 1977, 14, 114–119.
  7. Boyd PA, Keeling JW: Congenital abnormalities; prenatal diagnosis and screening. In: Fetal and neonatal pathology. Eds.: Keeling JW, Khong TY, Springer London 2007, 4th ed., 123–161.
  8. Supports Forums. 2014. Patau’s syndrome. Retrieved from http://www.depression-guide.com/learning-disability/ pataus-syndrome.htm
  9. Houlihan OA, O’Donoghue K: The natural history of pregnancies with a diagnosis of trisomy 18 or trisomy 13; a retrospective case series. BMC Pregnancy Childbirth 2013, 18, 209–218.
  10. Parker MJ, Budd JL, Draper ES, Young ID: Trisomy 13 and 18 in a defined population: epidemiological, genetic and prenatal observations. Prenat Diag 2003, 23, 856–860.
  11. Taylor AI: Autosomal trisomy syndromes: A detailed study of 27 cases of Edwards’ syndrome and 27 cases of Patau’s syndrome. J Med Genet 1968, 5, 227–241.
  12. Pilu G, Nocolaides KH: Diagnosis of fetal abnormalities. In: The 18–23-week scan. Eds.: Parthenon Publishing Group, Casterton Hall, Carnforth Lancs. LA62La, UK 1999, 99–126.
  13. Janiak K, Kaczmarek P, Krasoń A, Nowicki G, Piotrowicz M, Respondek-Liberska M: Przydatność badania echokardiograficznego płodu w diagnostyce zespołu Patau (analiza 11 przypadków). Gin Pol 2002 73, 606–612.
  14. Dudarewicz L: 2014. Wady wrodzone. Retrieved from http://www.usg-3d.pl/wad_wrodz.html
  15. Fitzsimmons JS, Filshie GM, Hill As, Kime R: Antenatal diagnosis of trisomy 13 with unexpected increase in alpha-feto protein. J Med Genetics 1976, 13, 400–412.
  16. Conen PE, Erkman B: Frequency and occurrence of chromosomal syndromes I. D–trisomy. Am J Dis Child 1966,111, 374–376.
  17. Nicolaides KH, Sebire NJ, Snijders RJM: The 11–14-week scan. In: The diagnosis of fetal abnormalities. Eds.: The Parthenon Publishing Group. New York–London 1999, 9–12.
  18. Locock L, Crawford J, Crawford J: The parent’s journey: continuing a pregnancy after a diagnosis of Patau’s syndrome. BMJ 2005, 331, 1186–1191.
  19. Lin HY, Lin SP, Chen YJ, Hsu CH, Kao HA, Chen MR, Hung HY, Ho CS, Chang JH, Huang FY, Tsai TC, Lin DS, Chan WT: Clinical characteristics and survival of trisomy 13 in medical center in Taiwan, 1985–2004. Pediatr Int 2007, 49, 380–386.
  20. Behrman R: Podręcznik pediatrii; Wyd Nauk PWN, Warszawa 1995.
  21. Jakubowski L: 2014. Badania genetyczne. Retrieved from http://www.genetyka-ginekolog.pl/badanie_kariotypu/ info_ogolne.php
  22. Carr DH: Chromosome studies in abortuses and stillborn infants. Lancet 1963, 283 (7308), 603–606.
  23. Morris JK, Savva GM: The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. Am J Med Genet 2008, 146, 827–832.
  24. Boyd PA, Maher EJ, Lindenbaum RH, Hoogwerf Am, Redman C, Crocker M: Maternal 3, 13 chromosome insertion, with severe pre-eclampsia. Clin Genet 1995, 47, 17–21.
  25. Boyd PA, Lindenbaum RH, Redman C: Pre-eclampsia and trisomy 13: a possible association. Lancet 1987, 2, 425–427.
  26. Pedersen BW, Gronlund A: Severe pre-eclampsia and fetal trisomy in a multiparous woman. Ugeskr Laeger 2003, 165, 2108–2109 [article in Danish].
  27. Barlow-Stewart K: 2007. DNA Genetic testing-screening for genetic conditions and genetic susceptibility [pdf]. Retrieved from http://www.genetics.edu.au
  28. Seeds JW: Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol 2004, 191, 607–615.
  29. Krasoń A, Janiak K, Kaczmarek P, Respondek-Liberska M: Znaczenie badania echokardiograficznego w przebiegu farmakoterapii płodu lub ciężarnej. Ginekol Pol 2002, 73, 645–651.
  30. Goetzinger KR, Stamilio DM, Dicke JM, Macones GA, Odibo AO: Evaluating the incidence and likelihood ratios for chromosomal abnormalities in fetuses with common nervous system malformations. Am J Obstet Gynecol 2008, 199, 285.e1–285.e6.
  31. Costa AD, Schultz R, Rosemberg S: Alobar holoprosencephaly and trisomy 13 (Patau syndrome). Autopsy and Case Reports 2013, 3, 5–10.
  32. Solomon BD, Rosenbaum KN, Meck JM, Muenke M: Holoprosencephaly due to numeric chromosome abnormalities. AmJ Genet C Semin Med Genet 2010, Feb 15, 154, 146–148.
  33. Brizot ML, Schultz R, Patroni LT, Lopes LM, Armbruster-Moraes E, Zugaib M: Trisomy 10: ultrasound features and natural history after first trimester diagnosis. Prenat Diagn 2001, 21, 672– 675.
  34. Armbruster-Moraes E, Schultz R, Brizot ML, Miyadahira S, Zugaib M: Holoprosencephaly in a Klinefelter Foetus. Am J Med Genet 1999, 85, 511–512.
  35. Carrey JC: 2015. Trisomy 13 facts [pdf]. Retrieved from http://trisomy.org/trisomy-13-facts-2/
  36. Lehman CD, Nyberg DA, Winter TC, Kapur RP, Resta RG, Luthy DA: Trisomy 13 syndrome: prenatal us findings in a review of 33 cases. Radiology 1995, 217–222.
  37. Moerman P, Fryns JP, van der SteenK, Kleczkowska A, Lauweryns J: The pathology of trisomy 13 syndrome. A study of 12 cases. Hum Genet 1988, 80, 349–356.
  38. Ballarati L, Rossi E, Bonati MT, Gimelli S, Maraschino P, Finelli P, Giglio S, Lapi E, Bedeschi MF, Guerneri S, Arrigo G, Particelli MG, Mattina T, GuzzardiO, Pecile V, Police A, Scarano G, Larizza L, Zuffardi O, Giardino D: 13q deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients. J Med Genet 2007, 44, e60. Retrieved from http://www.nebi.nlm.nih.gov/pmc/articles/ PMC2597907/
  39. Olsen Cl, Hughes JP, Youngblood LG, Stimac-Sharpe M: Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York State, 1984–1989. Am J Med Genet 1997, 73, 217–226.
  40. Folkerth RD, Lidov HCG: Congenital malformations, perinatal diseases, and phacomatoses. In Neuropathology, Ed.: Prayson RA, 2nd edition. Philadephia, Elsevier 2012, Chapter 4, 870–877.
  41. DeMyer WE, Zeman W, Palmer C: the face predicts the brain, diagnostic significance of medial facial anomalies from holoprosencephaly (arhinencephaly). Pediatrics 1964, 34, 256–263.
  42. James D, Steer PJ, Weiner CP, Gonik B: High risk pregnancy. 4thedition. Elsevier. 2011. Copyright ISBN-13.
  43. Jorde LB, Carey JC, White RL: 2001. Photographs. Patau syndrome (Trisomy13). Retrieved from: http://www. medgen.genetics.utah.edu/photographs/pages/trisomy-13.htm via http://www.hcfor.pl/choroby-mutacje-genetyczneanomalie/1279-trisomia-13-czyli-zesp-pataua.html
  44. [Guideline] American College of Obstetricians and Gynecologists (ACOG). Screening for fetal chromosomal abnormalities. Washington (DC): American College of Obstetricians and Gynecologists (ACOG) 2007 Jan. 11p. ACOG practice bulletin no. 77.
  45. Siemińska-Piekarczy B, Młynarska-Zduniak E: Symptomatologia zespołu Patau – obserwacje własne. Czas Stomatol 2006, LIX, 8, 587–591.
  46. Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM: Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 2003, 111, 777–784.
  47. Chen M, Yeh GP, Shih JC, Wang BT: Trisomy 13 mosaicism: study of serial cytogenetic changes in a case from early pregnancy to infancy. Prenat Diagn 2004, 24, 137–143.
  48. Cole J: 2008. Living with trisomy 13. Retrieved from http://www.somi.org/newspubs/profiles/photos/jenna_cole.jpg
  49. Best RG: Patau syndrome treatment & management 2014. Retrieved from http://emedicine.medscape.com/ article/947706-treatment.
  50. Ogilvie C, Hulten M Unique: 2005. Robertsonian translocation [pdf]. Retrieved from http://www.rarechromo. org./information/other/robertsoniantranslocation.
  51. Therman E, Susman B, Denniston C: The nonrandom participation of human acrocentric chromosomes in Robertsonian translocations. Ann Hum Genet 1989, 53, 49–65.
  52. Nembhard WN, Waller DK, Sever LE, Canfield MA: Patterns of first year survival among infants with selected congenital anomalies in Texas, 1995–1997. Teratology 2001, 64, 267–275.
  53. Hujoel PP, Bollen Am, Mueller BA: First-year mortality among infants with facial clefts. Cleft Palate Craniofac J 1992, 29, 451–455.
  54. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, EhrichM, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA: DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012, 14, 296–305.
  55. Butler LJ, Reiss HE, France NE, Briddon S: Antenatal diagnosis of Patau’s syndrome (trisomy 13) including a detailed pathological study of the fetus. J Med Genet 1973, 10, 367–370.
© Wroclaw Medical University